ANTX (STOCKS)
AN2 Therapeutics, Inc. Common Stock
$3.600000
+0.060000 (+1.69%)
Prev close: $3.540000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Eric Easom
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $135.66M
- Employees
- 36
- P/E (TTM)
- -3.30
- P/B (TTM)
- 1.69
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
3
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.18 | $-0.28 | +0.0954 | +34.64% |
|
Mar 2026 (Q1)
|
$-0.29 | $-0.23 | -0.0554 | -23.61% |
|
Dec 2025 (Q4)
|
$-0.29 | $-0.24 | -0.0452 | -18.46% |
|
Sep 2025 (Q3)
|
$-0.31 | $-0.22 | -0.0856 | -38.15% |